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Introduction
Tonsillar metastases are absolutely rare: in a series of 1,547 
tonsillar tumors only 12 (0.8%) were metastases (1). Similar 
results were reported in another study published by Hyams 
and colleagues (2). Overall few cases of lung cancers with 
tonsillar metastasis were described and the majorities were 
small cell lung cancer (SCLC) (3-8).
Case presentation
A 76 years old man was admitted at our emergency 
department because of dyspnea, associated to strep throat 
and difficulty swallowing, on April 2011. He was a former 
smoker of 30–40 cigarettes a day. His medical history 
included pulmonary emphysema, rickettsiosis, gouty 
arthritis, bilateral hypoacusis and cataract. 
A total body computed tomography (CT) scan revealed 
a solid mass of 3.5 cm in the left upper lobe, mediastinal 
lymphadenopathy and pleural effusion, without lesions in 
the bone, brain, liver and adrenal glands.
Pathologic diagnosis of SCLC was obtained from a 
bronchoscopy with biopsy. Contextually, a large formation 
next to the lateral right portion of the tongue was even 
detected. A head and neck MRI disclosed a large mass 
arising from the right tonsil, displacing the soft palate 
(Figure 1). An incisional biopsy of tonsillar lesion showed 
a metastasis from SCLC. Hematoxylin and eosin-
stained sections revealed small carcinoma cells with 
scant cytoplasm and frequent mitotic figures (Figure 2). 
Immunohistochemical analysis resulted positive for neural 
cell adhesion molecule (CD56) and thyroid transcription 
factor-1 in tumor cells (Figures 3,4). 
The patient received a chemotherapy regimen including 
carboplatin (AUC 6) day 1 and etoposide (100 mg/mq) day 
1–3, q21. A stable disease lasting 6 months was detected by a 
whole body CT scan. However, a further CT scan, revealed 
brain metastases 3 months after the end of chemotherapy. 
The patients received a whole-brain radiotherapy followed 
by a second line chemotherapy with topotecan (1.5 mg/mq 
day 1–5 q21).
Finally, patient died for progressive disease 3 months 
later, with an overall survival of 14 months.
Discussion
SCLC is known to be the most frequent histological 
type of tonsillar metastases, however the way of tumor 
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cells spreading to tonsil remains controversial. Both 
hematogenous and retrograde lymphatic spreading of 
cancer cells can be considered (7). Prognosis of patients 
with tonsillar metastasis remains poor. The paucity 
of casuistic prevented to have effective treatments. 
Nonetheless, recently Gottschling and colleagues reported 
a long-term response to gefitinib in a KRAS-mutation 
positive, metastatic tonsil carcinoma with cancer stem-like 
cell features (8). 
We reported a case of synchronous tonsillar metastases in 
a SCLC patient with a similar survival compared to patients 
previously evaluated. For the purpose of a complete staging 
in cancer patients, especially in those with SCLC, we would 
highlight the importance of oral cavity evaluation as a part 
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Figure 1 T2 weighted MRI scan of the oropharynx showing the 
small cell lung cancer (SCLC) right palatin tonsil metastasis that 
appears strongly hyperintense if compared with striated muscles 
and easily delimitable.
Figure 2 Hematoxylin and eosin picture (100×) of the tissue 
section, showing a minute fragment of tissue within the infiltration 
of small cell carcinoma with high mitotic activity.
Figure 3 Image of the tissue section (100×) stained with anti-
CD56 monoclonal antibody, showing high and uniform positivity 
of virtually all cells of the tumor.
Figure 4 Image of the tissue section (100×) stained with monoclonal 
anti-TTF1, showing focal nuclear positivity of the tumor.
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Informed Consent: Written informed consent was obtained 
from the patient for publication of this manuscript and any 
accompanying images.
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